Stock analysis, price data, and AI-powered insights for INmune Bio Inc (INMB).
INmune Bio Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for INMB.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). INMB Stock Intelligence Report. [stoxpulse.com/stocks/inmb]
Disclaimer: The information on this page about INmune Bio Inc (INMB) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for INmune Bio Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Inmune Bio Inc. Announces New Preclinical Data At ...
5d ago
INmune Bio To Present New Preclinical Data For Ant...
5d ago
StoxPulse AI results for INMB: Pulse Score 52.5/100. Primary sentiment trends from 2 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$36.4M
P/E Ratio
—
EPS
$-0.24
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Inmune Bio Inc. Announces New Preclinical Data At Aacr 2026 Demonstrating Inb03 Overcomes Resistance and Reduces Metastases in Her2-Positive Breast Cancer Models
INmune Bio To Present New Preclinical Data For Anti-Tumor Growth Treatment INB03; Data To Be Presented At The American Association For Cancer Research Annual Meeting On April 17-22